4CAITier 5
Caris Life Sciences, Inc. 4
0002072013-26-000004
View on SEC EDGARLuke Thomas Power had 9,771 Caris Life Sciences, Inc. common shares withheld for taxes upon RSU vesting, leaving him with 153,771 directly owned shares.
On May 15, 2026, Luke Thomas Power, Senior Vice President, Chief Financial Officer, and Chief Accounting Officer of Caris Life Sciences, Inc., had 9,771 shares of common stock withheld at a price of $15.25 per share (about $149,000 in value) to cover taxes due upon the vesting and settlement of restricted stock units (RSUs), resulting in post-transaction direct ownership of 153,771 shares. This is a routine tax-withholding event associated with equity compensation rather than an open-market sale or purchase.
Filing Facts
- CIK
- 2019410
- Ticker
- CAI
- Form
- 4
- Source Type
- fda
- Accession
- 0002072013-26-000004
- Alert Tier
- 5